A recent study published in Nature Medicine has provided promising evidence that a new form of deep brain stimulation, known ...
The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson’s disease (ADAPT-PD) trial.
Abbott Laboratories will begin clinical trials for its deep-brain stimulation system for treatment-resistant depression after receiving Breakthrough Device designation from the U.S. Food and Drug ...
Guided subthalamic nucleus deep brain stimulation programming for Parkinson disease,” published in the September 2024 issue ...
Deep brain stimulation (DBS) is a neurosurgical procedure that entails the implantation of electrodes in specific brain regions, to subsequently stimulate these regions via high frequency electric ...
Check if you have access via personal or institutional login Deep brain stimulation (DBS) is now a firmly established treatment for movement disorders, and an increasing body of evidence supports DBS ...
Deep brain stimulation (DBS) has evolved as an important and established treatment for movement disorders. While DBS is not a cure for movement disorders, it can successfully treat symptoms by ...
The approach, called adaptive deep brain stimulation, or aDBS, uses methods derived from AI to monitor a patient’s brain activity for changes in symptoms. When it spots them, it intervenes with ...
Deep brain stimulation (DBS) is a neurosurgical surgery that uses implanted electrodes and electrical stimulation to treat movement disorders in a Parkinson's disease patient.
An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...
Deep Brain Stimulation (DBS) is an effective and safe treatment for motor symptoms in patients with movement disorders such as Parkinson’s disease. In addition to motor symptoms such as tremors, ...
Volkmann and colleagues (2014) aimed to ascertain whether deep brain stimulation (DBS) would be effective for cervical dystonia cases that prove refractory to standard therapies. The authors ...